TH69074A - Lactoferrin Polypeptides for stronger bone health - Google Patents

Abstract

DC60 (24/10/46) Lactoferrin Pure polypeptides containing metals No more than 2 ions per molecule Contains or mixtures of polyp Tides and their sub-derivatives, polypeptides or their mixtures stimulate skeletal growth. Bone and help stop Bone breakdown Revealed Methods for treating bone disorders by using polypeptides or a combination thereof. Lactoferrin Pure polypeptides containing metals No more than 2 ions per molecule Contains or mixtures of polypeptides and their derivatives, such polypeptides or mixtures stimulate the growth of the structure. Bone and help stop Bone decay was also revealed. Methods for treating bone disorders by using polypeptides or a combination thereof.

Claims (15)

1. Lacfoetferrin is a pure polypeptide or derivative of those compounds containing no more than 2 metal ions per molecule. This polypeptide stimulates the growth of bone marrow cells and inhibits bone resorption. 2. Lactoferrin, a polypeptide of claim 1, whereby the polypeptide contains 2 metal ions per molecule. 3. Lactoferrin polypeptide of claim 1 or 2, where the polypeptide contains iron ions, copper ions, chromium ions, cobalt ions, manganese ions, zinc ions, or magnesium ions. 4. Lactoferrin, a polypeptide of claim 3, where the polypeptide contains iron ions. 5. A mixture containing lactoferrin polypeptides of any one of the preceding claims and their partial derivatives. 6. A mixture of claim number 5, whereby the mixture contains a hydrolysate of any lactoferrin polypeptide of claims number 1 through 4. 7. An invigorating mixture containing lactoferrin, polypeptides, or derivatives of any of the compounds mentioned in any of the claims in Claims 1 through 4. 8. A strengthening mixture which includes a combination of the claims of Article 5 or Article 6. 9. A pharmaceutical mixture containing lactoferrin, polypeptides or derivatives of any of the compounds under claims 1 through 4, and a pharmaceutically acceptable carrier. 10. A pharmaceutical mixture which contains a combination of the claims of Article 5 or Article 6 and a pharmaceutically acceptable carrier substance. 11. The use of lactoferrin, polypeptides, or derivatives of any of the claims under claims 1 through 4 in the manufacture of pharmaceuticals for the treatment of bone disorders. 12. The use of compounds under Patent 5 or 6 in the manufacture of pharmaceuticals for the treatment of bone disorders. 13. The use of a combination of any of the claims under Claims 7 through 10 in the manufacture of pharmaceuticals for the treatment of bone disorders. 14. The use of lactoferrin, polypeptides, or derivatives of any one of the claims under claims 1 through 4 in the manufacture of formulations for use in stimulating bone cell growth and inhibiting bone degradation. 15. The use of mixtures, whether under patent 5 or 6, in the manufacture of formulations for use in stimulating the growth of skeletal cells and inhibiting bone resorption.